ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data.

Georgina V Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.